Product category: Patient monitoring systems / Measuring stations
The TetraGraph neuromuscular monitor is specifically designed to address the needs of perioperative monitoring of physiologic data in surgical patients receiving general anesthesia. The TetraGraph monitors (measures, analyzes and displays) muscle function in surgical patients receiving neuromuscular blocking agents (NMBAs).
The unique, user-friendly system includes the TetraGraph monitor, the TetraSens disposable electrosensors and the TetraCord connecting cable. Monitoring of neuromuscular function is critically important for patients undergoing general anesthesia for surgical procedures. Since patients receive NMBAs during general anesthesia to facilitate surgery, monitoring of the effects of NMBAs is paramount.
Senzime develops unique patient-oriented monitoring systems that make it possible to assess patients' biochemical and physiological processes before, during and after surgery. The portfolio of technologies includes bedside systems that enable automated and continuous monitoring of life-critical substances such as glucose and lactate in both blood and tissues, as well as systems to monitor patients’ neuromuscular function perioperatively and in the intensive care medicine setting.
The solutions are designed to ensure maximum patient benefit, reduce complications associated with surgery and anesthesia, and decrease health care costs. Senzime operates in growing markets that in Europe and the United States are valued in excess of $10 billion. The company's shares are listed on AktieTorget (ATORG:SEZI).